Effects of Ustekinumab Maintenance Therapy on Endoscopic Improvement and Histologic Improvement in the UNIFI Phase 3 Study in Ulcerative Colitis

(1) Janssen Research & Development, LLC,Spring House,United States

(2) University of California,San Diego,United States

(3) Icahn School of Medicine at Mount Sinai,New York,United States

(4) Robarts Clinical Trials Inc.,London,Canada

(5) Nancy University Hospital Inserm U 954,Vandoeuvre les Nancy,France

(6) KU Leuven,Leuven,Belgium

This item was part of the IBD II (Posters) session at UEG Week 2019

This item can be cited as: United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019